| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
64,920,000 |
| Market
Cap: |
1.01(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$13.43 - $23.54 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 31.4 |
| Insider 6 Months : 31.4 |
| Insider 3/6 Months : 63.1 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer therapies. Co.'s products include: Domvanalimab, which is an anti-TIGIT monoclonal antibody designed to promote sustained immune activation and tumor clearance; Etrumadenant, which is a dual A2a/A2b adenosine receptor antagonist, designed to inhibit the adenosine-driven impairment of tumor-infiltrating lymphocytes and myeloid cells; AB680, which is a potent and selective small-molecule CD73 inhibitor designed to provide differential benefits relative to monoclonal antibodies; and Zimberelimab, which is Co.'s anti-PD-1 antibody that Co. in-licensed to enable the development of its combination regimens.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
15,238,095 |
15,238,095 |
16,248,095 |
16,248,095 |
| Total Buy Value |
$319,999,995 |
$319,999,995 |
$339,452,595 |
$339,452,595 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
1 |
1 |
2 |
2 |
| Total Shares Sold |
110,657 |
141,439 |
237,875 |
329,459 |
| Total Sell Value |
$2,164,815 |
$2,731,452 |
$4,652,676 |
$7,003,905 |
| Total People Sold |
2 |
4 |
4 |
6 |
| Total Sell Transactions |
6 |
10 |
16 |
33 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rosen Terry J |
Chief Executive Officer |
• • – |
2019-06-04 |
4 |
B |
$7.75 |
$199,826 |
I/I |
25,770 |
3,001,401 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2019-06-03 |
4 |
B |
$8.16 |
$128,749 |
I/I |
15,770 |
2,975,631 |
2.66 |
- |
|
| Jaen Juan C. |
President |
• • – |
2019-06-03 |
4 |
B |
$8.25 |
$82,485 |
I/I |
10,000 |
2,764,240 |
2.66 |
- |
|
| Hemrajani Rekha |
See RemarksOfficer |
• – – |
2019-03-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
25,252 |
|
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-28 |
4 |
B |
$15.48 |
$164,845 |
I/I |
10,650 |
3,959,861 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-27 |
4 |
B |
$14.48 |
$115,586 |
I/I |
7,957 |
3,949,211 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-24 |
4 |
B |
$13.40 |
$66,363 |
I/I |
4,954 |
3,941,254 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-23 |
4 |
B |
$13.50 |
$28,800 |
I/I |
2,133 |
3,936,300 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-22 |
4 |
B |
$13.52 |
$29,777 |
I/I |
2,202 |
3,934,167 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-21 |
4 |
B |
$13.20 |
$36,828 |
I/I |
2,790 |
3,931,965 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-20 |
4 |
B |
$13.21 |
$17,186 |
I/I |
1,301 |
3,929,175 |
2.58 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-17 |
4 |
B |
$13.27 |
$63,713 |
I/I |
4,800 |
3,927,874 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-16 |
4 |
B |
$12.95 |
$115,649 |
I/I |
8,932 |
3,923,074 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-15 |
4 |
B |
$12.57 |
$167,240 |
I/I |
13,300 |
3,914,142 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-14 |
4 |
B |
$12.36 |
$76,239 |
I/I |
6,169 |
3,900,842 |
2.66 |
- |
|
| Jaen Juan C. |
President |
• • – |
2018-08-13 |
4 |
B |
$11.77 |
$37,168 |
I/I |
3,159 |
2,744,240 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-13 |
4 |
B |
$11.75 |
$38,534 |
I/I |
3,279 |
3,894,673 |
2.66 |
- |
|
| Jaen Juan C. |
President |
• • – |
2018-08-10 |
4 |
B |
$11.94 |
$30,796 |
I/I |
2,579 |
2,741,081 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-10 |
4 |
B |
$11.94 |
$30,451 |
I/I |
2,550 |
3,891,394 |
2.66 |
- |
|
| Jaen Juan C. |
President |
• • – |
2018-08-09 |
4 |
B |
$11.93 |
$50,855 |
I/I |
4,262 |
2,738,502 |
2.66 |
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-08-09 |
4 |
B |
$11.92 |
$48,869 |
I/I |
4,100 |
3,888,844 |
2.66 |
- |
|
| Kutzkey Tim |
10% Owner |
– – • |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,540,850 |
470,427 |
|
- |
|
| Alphabet Inc. |
10% Owner |
– – • |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
1,924,474 |
1,924,474 |
|
- |
|
| Alphabet Inc. |
10% Owner |
– – • |
2018-03-19 |
4 |
A |
$0.00 |
$0 |
I/I |
3,125,312 |
3,125,312 |
|
- |
|
| Rosen Terry J |
Chief Executive Officer |
• • – |
2018-03-19 |
4 |
B |
$15.00 |
$999,990 |
I/I |
66,666 |
3,884,744 |
2.66 |
- |
|
207 Records found
|
|
Page 8 of 9 |
|
|
0.08 (0.51%) 
